Sakys John's Form 4/A amendment
AmendedMesa Laboratories Inc (MLAB) · filed Aug 17, 2022
- Accession no.
- 0001228924-22-000026
- Filed
- Aug 17, 2022
- Trade date
- Aug 15-16, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Aug 17, 2022
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $401.1K. It was filed 2 days after the trade.
This amendment replaces 0001228924-22-000025 (filed Aug 17, 2022).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sakys JohnCIK 0001197710 | Officer (CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 15, 2022 | Common Stock | MOption exerciseAcquired | +628 | $70.56 | +$44,311.68 | 9,306 | Direct | |
| Aug 16, 2022 | Common Stock | MOption exerciseAcquired | +1,372 | $70.56 | +$96,808.32 | 10,678 | Direct | |
| Aug 15, 2022 | Common Stock | SSaleAcquired | +628 | $200.54 | +$125,939.12 | 10,050 | Direct | |
| Aug 16, 2022 | Common Stock | SSaleDisposed | −1,372 | $200.58 | −$275,195.76 | 8,678 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 15, 2022 | Common Stock | XIn-the-money exerciseDisposed | −628 | $0.00 | $0 | 31,174 | Direct | |
| Aug 16, 2022 | Common Stock | XIn-the-money exerciseDisposed | −1,372 | $0.00 | $0 | 29,802 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
1/7 exercisable on each anniversary of the 04/01/2015 grant date
- F2
Sale reported on this Form 4 was effected pursuant to a Rule 10B5-1 trading plan, adopted by the reporting person on June 14, 2022
- F3
Consists of 100 shares held by children of which Mr. Sakys is custodian